MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth

Newly developed clinic prescribing system will allow Doctors to prescribe MangoRx products from within practices and clinics

Dallas, Texas, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug (‘Mango’), its hair growth product (‘GROW’), and its FDA approved oral testosterone replacement therapy (TRT), ‘PRIME’, by MangoRx, powered by Kyzatrex^️, is excited to announce that it has officially launched its direct-to-clinics sales division offering doctors and medical practitioners the ability to prescribe MangoRx products to their patients directly from their offices, clinics and brick and mortar locations. The Company also reports that it has successfully onboarded its first medical health and wellness clinic based in Dallas, TX last week.

The Company believes that this direct-to-clinics initiative will assist in fueling a greater amount of recurring revenues while at the same time reducing customer acquisition costs (CACs) associated with traditional digital marketing strategies. The first of its kind within MangoRx’s direct competitor group, the Company will be deploying a boots-on-the-ground sales force with a mission to penetrate existing brick and mortar men’s health and wellness clinics across the United States, including but not limited to Med Spas, Low Testosterone clinics, and specialty doctors’ offices.

Jonathan Arango, MangoRx’s Co-Founder and President noted, “we are very excited for the launch of this direct-to-clinics initiative as this has been a part of our business plan and in the works since the 4^th quarter of 2023. Since we have launched our Mango ED products, many doctors have approached us asking how they could prescribe Mango to their existing patients. This led us to design our newly custom-built prescribing system that allows for the practitioner to prescribe MangoRx products – including our newly launched ‘PRIME’, by MangoRx, powered by Kyzatrex^️ – while at the same time acquiring a new MangoRx customer within our ecosystem.”